Business Context and Reporting Period
Company: Concentra Group Holdings Parent, Inc. (NYSE: CON)
Filing Type: Form 8-K (Current Report)
Date of Report: June 1, 2025
Reporting Period: Event-based report regarding the completion of an acquisition on June 1, 2025.
Key Financial Metrics
This filing reports a specific transaction rather than periodic financial results. Key metrics related to the transaction include:
- Acquisition Price: $55 million (subject to customary adjustments).
- Financing Method: Combination of cash on hand and available borrowing capacity under the existing revolving credit facility.
- Revenue/Profit/Cash Flow: The filing text does not provide specific revenue, profit, or cash flow figures for the acquired entity or the consolidated company for this period.
Material Changes
Completion of Acquisition: On June 1, 2025, Concentra Health Services, Inc. (a wholly owned subsidiary) consummated the acquisition of Onsite Innovations, LLC from Pivot Occupational Health, LLC.
- Asset Acquired: All outstanding equity interests of Onsite Innovations.
- Operational Impact: Onsite Innovations operates approximately 200 onsite health clinics at employer locations across over 40 states, providing occupational health, wellness, prevention, and performance services.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on June 2, 2025, confirming the consummation of the deal. The transaction was financed using existing liquidity resources (cash and credit facility).
Risks and Contingencies: The filing notes the purchase price is subject to customary adjustments. No specific forward-looking guidance or new risk factors were detailed in this specific 8-K text beyond the standard disclosure regarding the acquisition.
Investor Verification Checklist
- Verify the final purchase price after customary adjustments are applied to the initial $55 million.
- Review the impact of the acquisition on the Company's leverage ratios given the use of the revolving credit facility.
- Examine the attached Press Release (Exhibit 99.1) for detailed strategic rationale and integration plans.
- Monitor future 10-Q or 10-K filings for the financial contribution of the 200 newly acquired clinics.